38例肺炎支原体感染合并肝损害的治疗效果分析

Treatment Effect Analysis of 38 Cases of Mycoplasma Pneumoniae Infection Complicated with Liver Damage

目的探讨肺炎支原体(Mp)感染合并肝损害的治疗效果。方法选取2006年1月至2015年12月间,在某院住院诊断以肝脏损害为主要表现的Mp感染38例患者,采用t和X^2检验对治疗前后患者症状、检验结果对比分析。结果抗-Mp治疗3.1±0.9天体温降至正常,皮疹消退;3.9±0.7天呼吸道等症状消失,末梢血中心分叶细胞(NEU)比例恢复正常。治疗22.3±3.4天肝功正常。无明显不良反应和后遗症。结论 Mp感染合并肝损害表现为较典型急性肝炎消化道及全身症状,部分患者兼有呼吸道表现。及时足量大环内酯类联合左氧氟沙星抗-Mp及护肝治疗效佳。

Objective To investigate treatment effect of mycoplasma pneumonia combined with liver damage. Methods Between January 2016 and December 2015, 38 aduh inpatients with MP-associated hepatic damage were enrolled. With t and Х2 test, we analyzed the symptoms and changes of MP-associated hepatic damage, as well as the inspection results before and after treatment. Results Body temperature of patients reduced to the normal and rashes subsided 3.1＋0. 9 days after anti--MP and hepatic protection treatment, Respiratory symptoms disappeared and the ratio of NEU to white blood cells back to normal 3.9＋0. 9 days after treatment. Hepatic function was normal 22.3＋3.4 days after treatment. There were no obvious adverse reactions and sequelae with patients. Conclusions The main performance of MP-associated liver damage was digestive symptoms, such as acute hepatitis. Some was along with respiratory symptoms. Enough macrolide and levofloxacin in time was effective for MP-associated liver damage.